Table 4.
Adjusted odds of 30-day mortality in medicare patients who had survived hospitalization for sepsis (n = 4905).
| aOR (95% CI) | |
|---|---|
| BBRxa vs. NORxb | 0.59 (0.51, 0.68) |
| Male vs Female | 1.2 (1.03, 1.4) |
| Age 75–84 vs. 65–74 | 1.7 (1.42, 2.0) |
| Age ≥ 85 vs. 65–74 | 2.9 (2.4, 3.4) |
| Elix. 1 vs Elix 0 | 0.74 (0.44, 1.2) |
| Elix. 2 vs Elix 0 | 0.65 (0.43, 0.98) |
| Elix. 3 vs Elix 0 | 0.62 (0.44, 0.88) |
| Elix. >=4 vs Elix 0 | 0.73 (0.57, 0.92) |
| Black (African-American) vs. White non-Hispanic | 0.83 (0.66, 1.04) |
| Hispanic vs. White non-Hispanic | 0.73 (0.54, 0.97) |
| Asian vs. White non-Hispanic | 0.64 (0.42, 0.95) |
| Other vs. White non-Hispanic | 1.2 (0.67, 2.1) |
| Any surgical procedure | 1.5 (1.3, 1.8) |
| Congestive Heart Failure | 1.3 (1.12, 1.6) |
| Cancer | 2.5 (1.9, 3.2) |
c-statistic = 0.66.
Hosmer-Lemeshow goodness-of-fit p-value = 0.7515.
Diabetes, Chronic Obstructive Pulmonary Disease, History of Myocardial Infarction, Hypertension, Renal failure and Ischemic heart disease were removed from the model based on p-values > 0.05.
a
These patients were identified via Medicare Part D records to have been filling a prescription for a beta-blocker through the hospital admission date. Groups are the same for all tables.
b
These patients have never been on a beta-blocker per Part D records. Groups are the same for all tables.